Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! Please be sure to document all clinical activities daily.
The commercial product, Opthalgan, is discontinued. The P&T Committee approved the use of glycerin ophthalmic solution, prepared by a compounding pharmacy, at Huntsville Hospital.
The commercial product, Opthalgan, is discontinued. The P&T Committee approved the use of glycerin ophthalmic solution, prepared by a compounding pharmacy, at Huntsville Hospital.
Reviewed: August 23, 2006